We are live on
!
Find out more
BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.97B
1-Year Est. Return
44.96%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$5.17B
AUM Growth
-$207M
(-3.9%)
Cap. Flow
-$177M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
5.98%
Holding
1,388
New
128
Increased
302
Reduced
333
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hershey
HSY
|
+$13.1M |
| 2 |
K
Kellanova
K
|
+$12.1M |
| 3 |
Analog Devices
ADI
|
+$11.9M |
| 4 |
CenterPoint Energy
CNP
|
+$11.7M |
| 5 |
AutoZone
AZO
|
+$10.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$16.9M |
| 2 |
Caterpillar
CAT
|
+$15M |
| 3 |
Cencora
COR
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.3M |
| 5 |
JPMorgan Chase
JPM
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.4% |
| 2 | Industrials | 11.68% |
| 3 | Energy | 11.22% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Technology | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIOX
1201
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $164K | ﹤0.01% |
244,900
-100,000
| -29% | -$84.9K |
|
1202
Gain Therapeutics
GANX
$77.6M
| $163K | ﹤0.01% |
40,000
-10,000
| -20% | -$41.8K |
|
1203
Disc Medicine
IRON
$2.97B
| $163K | ﹤0.01% |
3,917
| – | – |
|
|
UNAM
1204
DELISTED
Unico American Corp
UNAM
| $160K | ﹤0.01% |
54,500
| – | – |
|
|
EAR
1205
DELISTED
Eargo, Inc. Common Stock
EAR
| $159K | ﹤0.01% |
+1,500
| New | +$148K |
|
1206
United States Antimony
UAMY
$1.02B
| $158K | ﹤0.01% |
245,500
-13,000
| -5% | -$6.35K |
|
1207
CalciMedica
CALC
$10.9M
| $155K | ﹤0.01% |
9,000
+2,571
| +40% | +$49K |
|
1208
HCW Biologics
HCWB
$5.45M
| $155K | ﹤0.01% |
236
+42
| +22% | +$22.4K |
|
1209
MIND Technology
MIND
$46.2M
| $155K | ﹤0.01% |
12,332
| – | – |
|
|
CLYM
1210
Climb Bio
CLYM
$804M
| $154K | ﹤0.01% |
+18,400
| New | +$172K |
|
1211
Cibus
CBUS
$138M
| $153K | ﹤0.01% |
2,936
-1,000
| -25% | -$74.7K |
|
|
CARM
1212
DELISTED
Carisma Therapeutics
CARM
| $151K | ﹤0.01% |
12,500
| – | – |
|
|
ENSV
1213
DELISTED
Enservco Corp.
ENSV
| $151K | ﹤0.01% |
56,093
| – | – |
|
1214
Inuvo
INUV
$17M
| $150K | ﹤0.01% |
30,600
| – | – |
|
1215
CPI Aerostructures
CVU
$68.5M
| $148K | ﹤0.01% |
50,000
+35,000
| +233% | +$91.6K |
|
1216
Elutia
ELUT
$37.6M
| $148K | ﹤0.01% |
+24,900
| New | +$147K |
|
1217
Magyar Bancorp
MGYR
$123M
| $148K | ﹤0.01% |
12,579
| – | – |
|
1218
Ocean Power Technologies
OPTT
$49.9M
| $148K | ﹤0.01% |
105,000
+80,000
| +320% | +$102K |
|
1219
Xcel Brands
XELB
$6.6M
| $148K | ﹤0.01% |
9,920
| – | – |
|
|
TTOO
1220
DELISTED
T2 Biosystems, Inc
TTOO
| $148K | ﹤0.01% |
57
| – | – |
|
1221
Pluri
PLUR
$19.6M
| $145K | ﹤0.01% |
8,750
-6,250
| -42% | -$90.1K |
|
1222
Serina Therapeutics
SER
$36M
| $145K | ﹤0.01% |
4,827
| – | – |
|
|
SUNE
1223
SUNation Energy
SUNE
$10.8M
| – | – |
0
| – | – |
|
1224
Biodesix
BDSX
$248M
| $144K | ﹤0.01% |
4,250
-1,000
| -19% | -$65.4K |
|
|
ZYXI
1225
DELISTED
Zynex
ZYXI
| $144K | ﹤0.01% |
+23,143
| New | +$163K |
|
Similar funds
SNT
MA
FFB
AM
SGM
PAMP
SMFG
SIA
Bridgeway Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Bridgeway Capital Management held 1,388 positions worth $5.17B, down 3.9% from $5.38B the previous quarter. Its ten largest holdings account for 6% of the portfolio.
Bridgeway Capital Management withdrew a net $177M in Q1 2022, closing 82 positions and reducing 333 holdings. Its most notable exit was US Bancorp, an estimated $16.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Industrials and Energy.
Against the trend, Bridgeway Capital Management opened a new position in Hershey worth $14M.
- Bridgeway Capital Management's largest Q1 2022 buy was Hershey: 64,550 shares worth $14M.
- Bridgeway Capital Management added most to Kellanova in Q1 2022, an estimated $12.1M increase.
- Bridgeway Capital Management's biggest Q1 2022 reduction was ConocoPhillips, cutting an estimated $14.3M.
- Bridgeway Capital Management fully exited US Bancorp in Q1 2022, selling an estimated $16.9M.
- Bridgeway Capital Management's ten largest holdings make up 6% of its $5.17B portfolio in Q1 2022.
- Bridgeway Capital Management opened 128 new positions and closed 82 in Q1 2022.
- Bridgeway Capital Management's portfolio value fell 3.9% quarter-over-quarter to $5.17B.
Based on Bridgeway Capital Management's 13F filing for Q1 2022, filed 16 May 2022.